Skip to main content
Premium Trial:

Request an Annual Quote

Plus, You Get to Add 'Patent Examiner' to Your CV

Andy Oram has a post at O'Reilly Radar about positive results from the Peer-to-Patent project, which he calls "one of the most audacious experiments in Internet activism in our day." Peer-to-Patent uses a wiki-style approach to determine whether patent claims are indeed new, inviting technology experts to look at patent applications and then post any prior art relevant to them. "First, people are signing up: over 2,000 so far. Second, they're submitting prior art: 202 pieces," Oram writes. "Most important: they're enjoying the work and would volunteer again."

 

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.